Testing for antiphospholipid antibodies: problems and solutions.

S S Pierangeli, A E Gharavi, E N Harris
Author Information
  1. S S Pierangeli: Morehouse School of Medicine, 720 Westview Drive SW, Atlanta, GA 30310-1495, USA. pierans@msm.edu

Abstract

The first aCL test was developed in 1983 and subsequently standardized. Although new and more specific tests have become available, the aCL ELISA and the LA tests are still the first choice to be used in diagnosis of APS. Newer tests such as the anti beta 2 GP1 ELISA and the APhL ELISA Kit (Louisville APL Diagnostics) use somewhat different antigens and likely provide a more specific (and possibly more reliable) diagnosis of APS while retaining good-to-excellent sensitivity. Other tests, such as ELISA for prothrombin antibodies and annexin V antibodies, are still undergoing development and will require standardization and extensive evaluation. We thank Dr Isabel Abreu and Dr Mittermeyer B. Santiago for performing some of the studies reported in this review.

MeSH Term

Antibodies, Anticardiolipin
Antibodies, Antiphospholipid
Antiphospholipid Syndrome
Enzyme-Linked Immunosorbent Assay
Female
Humans
Mass Screening
Pregnancy
Pregnancy Complications
Reproducibility of Results
Sensitivity and Specificity

Chemicals

Antibodies, Anticardiolipin
Antibodies, Antiphospholipid

Word Cloud

Created with Highcharts 10.0.0testsELISAfirstaCLspecificstilldiagnosisAPSantibodiesDrtestdeveloped1983subsequentlystandardizedAlthoughnewbecomeavailableLAchoiceusedNewerantibeta2GP1APhLKitLouisvilleAPLDiagnosticsusesomewhatdifferentantigenslikelyprovidepossiblyreliableretaininggood-to-excellentsensitivityprothrombinannexinVundergoingdevelopmentwillrequirestandardizationextensiveevaluationthankIsabelAbreuMittermeyerBSantiagoperformingstudiesreportedreviewTestingantiphospholipidantibodies:problemssolutions

Similar Articles

Cited By